Register entry
Xiamen Panmai Technology Co., Ltd
Data as of · How to read this entry
- Registered sites
- 1
- Active NDC listings
- 0
- Live patents
- 0
- Countries
- 1
- Base
- China
Authorisation
Registered operations
Labelling1Finished drug manufacture1
Sites
Registered establishments
1| Establishment | Address | Registered for | FEI / DUNS |
|---|---|---|---|
| Xiamen Panmai Technology Co., Ltd | Room 3803, 38/F, Strait Pearl Plaza, 99 Yilan Road, Guanyinshan International Business Center, Siming District, Xiamen, Fujian 361000, China (CHN) | Labelling, Finished drug manufacture | 3030224420416680201 |
Neighbours
Registered in the same town
3- Xiamen Kang Zhongyuan Biotechnology Co., Ltd.Xiamen, CHN
- Xiamen LP Pharmaceutical Co., Ltd.Xiamen, CHN
- Xiamen Tiger Medical Company, LtdXiamen, CHN
Compare
Comparable companies in China
- Kingkey MBC Life Technology Group co., LTD.1 site · 158 NDC
- Zhejiang Guoyao Jingyue Aerosol Co Ltd1 site · 94 NDC
- Shenzhen iShan Technology Co Ltd1 site · 84 NDC
- Xiamen Kang Zhongyuan Biotechnology Co., Ltd.1 site · 68 NDC
- Changzhou Maokang Medical Products Co., Ltd1 site · 59 NDC
- Jianerkang Medical Co Ltd1 site · 56 NDC
- Humanwell PuraCap Pharmaceuticals (Wuhan) Co., Ltd1 site · 40 NDC
- Guangdong Aimu Biological Technology Co Ltd1 site · 39 NDC
- Shenzhen Xinxin Yunhai Technology Co., Ltd.1 site · 37 NDC
- Guangdong Quadrant Ecological Technology Co., Ltd.1 site · 35 NDC
Enquiry
Common questions
- Is Xiamen Panmai Technology Co., Ltd FDA approved?
- Xiamen Panmai Technology Co., Ltd holds 1 FDA-registered establishment in China. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
- Where are Xiamen Panmai Technology Co., Ltd's drugs manufactured?
- The FDA register lists Xiamen. Registered operations: labelling, finished drug manufacture.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.